Other specific arthropathies

M13_OTERSPECARTHR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M12.8 Hospital discharge: ICD-9 — 7164 Cause of death: ICD-10 — M12.8 Cause of death: ICD-9 — 7164 2 out of 7 registries used, show all original rules.	71
4. Check minimum number of events None	71
5. Include endpoints None	71
6. Filter based on genotype QC (FinnGen only)	70

Control definitions (FinnGen only)

Control exclude: M13_ARTHROPATHIES

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M12
Name in latin: Aliae arthropathiae specificae non alibi classificatae

NAME	M13_OTERSPECARTHR
CONTROL_EXCLUDE	M13_ARTHROPATHIES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M128
HD_ICD_9	7164
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M128
COD_ICD_9	7164
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other specific arthropathies based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: unknown.

No upset table: unknown.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	538	264	268
Only index persons	487	239	248
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	43.11	48.62	37.31
Only index persons	39.19	46.04	32.59

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	70	40	30
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	45.34	46.23	44.15

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
71: Matched controls
710

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M12.8

ICD-10 Finland

Other specific arthropathies, not elsewhere classified

+∞

71.3

7164A

ICD-9 Finland

Other and unspecified arthropathies, Transient arthropathy

+∞

16.3

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

24.7

14.4

A07EC01

ATC

sulfasalazine; oral, rectal

26.6

11.2

P01BA02

ATC

hydroxychloroquine; oral

34.2

11.2

L04AX03

ATC

methotrexate; systemic

16.7

10.8

M13.9

ICD-10 Finland

Arthritis, unspecified

39.1

10.8

M19.0

ICD-10 Finland

Primary arthrosis of other joints

28.5

10.7

M17.1

ICD-10 Finland

Other primary gonarthrosis

24.4

10.3

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

+∞

9.6

M25.5

ICD-10 Finland

Pain in joint

4.9

9.3

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

42.7

9.3

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

28.3

9.3

L01BA01

ATC

methotrexate; systemic

101.6

8.6

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

101.6

8.6

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

+∞

8.5

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

38.2

8.3

M16.1

ICD-10 Finland

Other primary coxarthrosis

28.6

7.8

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

+∞

7.4

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

+∞

7.4

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

16.0

7.2

L88

ICPC

Rheumatoid/seropositive arthritis

44.4

6.9

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

76.4

6.5

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

76.4

6.5

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037522) Nuclear Ab [Titer] in Serum

5.54

8.92

1.6

1.4

448.00

262.86

titre

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4.52

7.67

1.2

1.1

34.25

1.19

u/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4.45

7.32

1.2

16.94

13.48

iu/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

7.18

4.13

1.1

0.26

0.27

g/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

6.70

3.96

1.1

1.26

1.24

g/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

7.35

3.79

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

3.56

3.58

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3.84

2.82

7.4

4.2

1.98

1.01

mmol/l

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

6.43

2.75

1.2

1.3

—

(3037467) Urinalysis macro (dipstick) panel - Urine

359

2.33

2.67

5.8

3.9

—

(40758558) Short blood count panel - Blood

133

2.22

2.38

11.6

7.6

—

(3022217) INR in Platelet poor plasma by Coagulation assay

219

2.06

2.28

11.0

13.3

1.28

1.31

inr

—

(40760892) CBC W Ordered Manual Differential panel - Blood

248

2.03

2.21

9.2

5.5

—

(3022313) Gas panel - Capillary blood

3.47

2.17

6.4

3.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2.77

2.13

6.5

1.6

9.72

9.73

g/l

0.00

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

5.28

2.10

1.2

1.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

258

1.91

1.89

7.9

7.4

1.21

1.22

mmol/l

0.19

212

(3013512) EKG study

147

1.96

1.78

4.0

3.5

—

(3035350) Ketones [Presence] in Urine by Test strip

262

1.86

1.77

3.3

3.1

0.00

estimate

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.76

1.64

1.2

1.4

—

(3049717) Cytology report of Urine Cyto stain

3.18

1.62

2.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

3.18

1.62

2.8

1.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3.50

1.55

2.0

1.2

28.40

37.33

nmol/l

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

188

1.81

1.54

2.1

1.9

85.57

99.31

pmol/l

1.11

(3022145) Colonoscopy Study observation

2.24

1.54

1.3

—

(3045414) Leukocytes [Presence] in Urine

3.02

1.54

2.7

2.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

154

1.84

1.52

4.1

1.9

128.58

139.12

u/l

0.14

148

(3011397) Hemoglobin [Presence] in Urine by Test strip

113

1.93

1.51

3.3

2.9

—

(3019225) pH of Specimen

2.31

1.41

4.9

5.5

—

(3008898) HLA-B27 [Presence]

3.08

1.38

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

2.63

1.33

3.2

4.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

260

1.68

1.31

4.6

4.1

0.00

estimate

—

(3012516) Albumin [Mass/volume] in Urine

154

1.73

1.25

3.2

3.1

238.13

479.88

mg/l

0.22

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

182

1.68

1.20

5.2

3.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.07

1.13

1.4

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.24

1.09

1.7

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.09

1.09

2.4

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.80

1.08

1.4

—

(3042936) Bacteria identified in Isolate by Culture

1.95

1.05

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

380

1.60

1.04

3.1

3.0

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

555

1.92

1.04

16.7

11.3

79.92

84.49

ml/min/173m2

0.84

459

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.87

0.99

1.8

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.25

0.94

2.3

2.2

—

(36304419) Bacteria [Presence] in Urine

140

1.60

0.90

3.9

2.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

204

1.52

0.87

3.7

3.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

232

1.51

0.87

2.3

2.2

—

(40761535) Cells panel - Urine sediment

1.75

0.82

5.1

2.9

—

(3023368) Bacteria identified in Blood by Culture

126

1.57

0.80

5.9

3.9

—

(3020682) Albumin/Creatinine [Ratio] in Urine

162

1.52

0.79

4.6

3.8

46.90

7.58

mg/mmol

0.66

101

(3000494) Fungus identified in Specimen by Culture

1.76

0.78

2.0

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.70

0.77

3.4

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.66

0.74

1.2

1.5

—

(3018095) Leukocytes [#/volume] in Urine

183

1.47

0.73

4.6

3.2

13.49

234.81

e6/l

0.60

122

(3007164) IgA [Mass/volume] in Serum or Plasma

123

1.50

0.66

2.2

1.5

1.92

2.41

g/l

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.78

0.65

3.6

1.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

597

1.73

0.64

20.7

13.8

3.98

mmol/l

0.01

582

(40768804) Tissue Pathology biopsy report

235

1.40

0.63

1.7

2.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.60

0.60

1.4

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

0.00

0.60

0.0

1.6

—

328.14

—

(3022621) pH of Urine by Test strip

1.78

0.59

2.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

153

1.43

0.59

2.9

2.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.68

0.57

1.8

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1.59

0.54

2.2

6.3

1.45

1.41

mmol/l

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.55

0.50

1.2

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

418

0.76

0.48

4.2

2.7

51.70

46.46

u/l

0.19

394

(3019060) Gas panel - Arterial blood

1.55

0.42

2.6

5.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.41

0.0

2.7

—

134.46

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

596

1.51

0.41

20.9

13.6

139.44

139.78

mmol/l

0.51

580

(3011288) Drugs identified in Urine by Screen method

0.00

0.40

0.0

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

0.00

0.39

0.0

1.6

—

(40768797) Stomach Pathology biopsy report

1.35

0.39

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.63

0.38

1.0

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.47

0.36

1.7

1.8

—

(40761511) CBC panel - Blood by Automated count

621

1.55

0.35

18.8

11.4

—

(3026008) Bacteria identified in Urine by Culture

147

1.30

0.35

3.4

3.0

—

(3000492) Spirometry study

1.36

0.35

4.3

1.5

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.30

0.31

2.9

7.2

103.14

104.38

mmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.30

0.31

3.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.35

0.29

1.8

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.35

0.29

1.8

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.30

0.29

2.0

4.25

6.43

umol/l

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.26

0.28

7.9

6.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.30

0.23

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.30

0.23

1.8

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

101

0.77

0.23

1.5

2.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.21

0.0

1.3

—

(3024928) Oxygen saturation in Venous blood

0.00

0.21

0.0

3.5

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.21

0.0

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

113

1.18

0.14

2.5

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

125

1.15

0.11

3.9

4.4

23.06

20.83

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.15

0.10

1.8

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.17

0.10

1.8

1.4

—

(3012544) pH of Venous blood

1.09

0.10

3.0

4.8

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1.04

0.08

2.3

1.9

120.83

34.00

u/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.76

0.08

1.0

2.1

—

(3044889) 12 lead EKG panel

399

1.07

0.05

3.7

—

(3003694) ABO and Rh group [Type] in Blood

153

1.06

0.01

1.2

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

158

1.02

0.00

2.3

1.9

—

(1761868) Lipid panel - Serum or Plasma

227

1.02

0.00

3.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

185

1.04

0.00

2.6

2.2

55.47

54.24

u/l

0.07

170

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

0.0

18.6

—

1636.88

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.0

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

0.0

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.6

—

(4062490) Immunoglobulin typing, IgG

0.00

0.0

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.0

2.8

—

63.88

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

12.11

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

0.0

16.3

—

956.13

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

-0.00

0.0

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

3.9

—

165.67

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

0.00

-0.00

0.0

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.2

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

1.8

—

14.72

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

0.81

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.3

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

2.5

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.0

—

8.82

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

-0.00

0.0

1.0

—

(4281824) Cell count and differential, peritoneal fluid

0.00

-0.00

0.0

1.0

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(21494755) Public health laboratory ask at order entry panel

1.00

-0.00

1.1

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.00

-0.00

0.0

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

154.07

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

-0.00

0.0

2.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

-0.00

0.0

4.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

0.00

-0.00

0.0

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.54

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

0.00

-0.00

0.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

6.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

2.82

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.5

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

-0.00

0.0

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

82.40

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

1.9

—

13.71

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.4

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_OTERSPECARTHR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_OTERSPECARTHR.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: M13_OTERSPECARTHR – Other specific arthropathies

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other specific arthropathies

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints